Ruiz-Estevez, M.
Crane, A. T.
Rodriguez-Villamil, P.
Ongaratto, F. L.
You, Yun
Steevens, A. R.
Hill, C.
Goldsmith, T.
Webster, D. A.
Sherry, L.
Lim, S.
Denman, N.
Low, W. C.
Carlson, D. F.
Dutton, J. R.
Steer, C. J.
Gafni, O.
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK117286-01)
Article History
Received: 1 March 2021
Accepted: 19 April 2021
First Online: 19 May 2021
Declarations
:
: Not applicable.
: Not applicable.
: D.F.C. serves as C.S.O./Senior Vice President of Research and Development at Recombinetics, Inc.; W.C.L. served as C.S.O. of Regenevida a Division of Recombinetics, Inc. during the initial phase of this project; all the authors with Recombinetics, Inc. affiliation are employees and shareholders of the company; the other authors declare that they have no competing interests.